The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hatfield Jeffrey S. since 2015.
The trader's CIK number is 1609879.
At the time of the last reporting, Hatfield Jeffrey S. was the Chief Executive Officer of Vitae Pharmaceuticals, Inc. (stock ticker symbol VTAE).
Also see all insider trading activities at Vitae Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | VTAE | 0 | $0 | 50,000 | $1,040,499 | 0 | $0 |
| 2015 | VTAE | 0 | $0 | 22,524 | $382,908 | 96,273 | $223,552 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-09-14 | VTAE | Sale | 50,000 | 20.81 | 1,040,499 |
| 2015-12-28 | VTAE | Option Ex | 26,537 | 3.45 | 91,552 |
| 2015-12-23 | VTAE | Sale | 22,524 | 17.00 | 382,908 |
| 2015-12-23 | VTAE | Option Ex | 22,524 | 3.45 | 77,707 |
| 2015-03-06 | VTAE | Option Ex | 8,115 | 1.15 | 9,332 |
| 2015-01-22 | VTAE | Option Ex | 39,097 | 1.15 | 44,961 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hatfield Jeffrey S. (Chief Executive Officer of Vitae Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.